It is possible that MFSs and UPSs initially develop as relatively well-differentiated fibroblastic/myofibroblastic sarcomas originating from CD34 + SFCs, but lose their CD34 expression while simultaneously gaining highly malignant features. This evidence concerns the gene CD34 and sarcoma.